. 2016 Mar 4;3(2):71–84. doi: 10.18632/oncoscience.295

Table 1. Inhibition of neovascularization.

Treatment	Blood vessels ± SE	Relative Area of Blood Vessels ± SE %
Control-PBS	44±381^a	0.7±9.7^a
Avastin (5mg/kg x2/week)	43±317^a	0.9±5.1^b
hrRNASET2 (1mg/kg x3/week)	38±134^b	0.6±3.6^b
hrRNASET2 (0.5 mg/kg x3/week)	21±118^b	0.8±4.0^b
hrRNASET2 (0.05mg/kg x3/week)	14±117^b	1.3±5.2^b

Different letters indicate a significant difference at P<0.01.

n=10 microscopic fields for each treatment.